Coldstream Capital Management Inc. Decreases Stock Position in Integer Holdings Co. (NYSE:ITGR)

Coldstream Capital Management Inc. reduced its position in Integer Holdings Co. (NYSE:ITGR) by 9.5% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,097 shares of the medical equipment provider’s stock after selling 221 shares during the period. Coldstream Capital Management Inc.’s holdings in Integer were worth $273,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Earnest Partners LLC boosted its stake in Integer by 3.2% during the 2nd quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider’s stock valued at $139,911,000 after acquiring an additional 37,340 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of Integer by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 764,528 shares of the medical equipment provider’s stock valued at $99,408,000 after purchasing an additional 9,421 shares in the last quarter. Loomis Sayles & Co. L P lifted its position in shares of Integer by 3.0% during the third quarter. Loomis Sayles & Co. L P now owns 538,027 shares of the medical equipment provider’s stock worth $69,943,000 after purchasing an additional 15,446 shares during the last quarter. Congress Asset Management Co. grew its stake in Integer by 3.9% in the third quarter. Congress Asset Management Co. now owns 488,785 shares of the medical equipment provider’s stock worth $63,542,000 after purchasing an additional 18,303 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its holdings in Integer by 1.2% in the third quarter. Charles Schwab Investment Management Inc. now owns 404,029 shares of the medical equipment provider’s stock valued at $52,524,000 after buying an additional 4,946 shares during the last quarter. 99.29% of the stock is owned by hedge funds and other institutional investors.

Integer Trading Down 0.2 %

Shares of NYSE:ITGR opened at $138.37 on Tuesday. The company has a quick ratio of 2.09, a current ratio of 3.28 and a debt-to-equity ratio of 0.67. The company’s 50-day moving average price is $133.97 and its 200 day moving average price is $125.90. The company has a market cap of $4.64 billion, a PE ratio of 42.71, a P/E/G ratio of 2.02 and a beta of 1.12. Integer Holdings Co. has a fifty-two week low of $94.56 and a fifty-two week high of $142.76.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 EPS for the quarter, beating the consensus estimate of $1.36 by $0.07. The company had revenue of $431.42 million for the quarter, compared to analyst estimates of $440.59 million. Integer had a net margin of 6.70% and a return on equity of 11.63%. Integer’s revenue was up 8.7% compared to the same quarter last year. During the same quarter last year, the business earned $1.27 earnings per share. Sell-side analysts anticipate that Integer Holdings Co. will post 5.33 earnings per share for the current year.

Analyst Upgrades and Downgrades

ITGR has been the topic of a number of research analyst reports. Wells Fargo & Company reaffirmed an “overweight” rating and set a $160.00 target price on shares of Integer in a report on Tuesday, December 3rd. KeyCorp raised their price objective on Integer from $139.00 to $144.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 15th. Piper Sandler reiterated an “overweight” rating and set a $140.00 target price (up previously from $125.00) on shares of Integer in a research note on Friday, October 25th. Citigroup raised their price target on shares of Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a research report on Wednesday, December 11th. Finally, Benchmark boosted their price objective on shares of Integer from $130.00 to $140.00 and gave the company a “buy” rating in a research report on Monday, October 21st. One research analyst has rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $145.44.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.